KeyBanc on salesforce.com (CRM): 'Understanding the Life Sciences Cloud Opportunity'
Tweet Send to a Friend
KeyBanc analyst Jackson Ader reiterated an Overweight rating and $400.00 price target on salesforce.com (NYSE: CRM).The analyst commented: "Understanding the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
